RecruitingNCT05048004

Cerebral Embolization During Pulmonary Vein Isolation

Cerebral Embolization During Pulmonary Vein Isolation: an Observational Study


Sponsor

Charite University, Berlin, Germany

Enrollment

20 participants

Start Date

Dec 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of the TCD-CA study is to determine the frequency of cerebral embolization during pulmonary vein isolation using continuous transcranial Doppler examination. Different parts of the procedure, different ablation techniques and periprocedural anticoagulation regimes will be compared.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • patients with atrial fibrillation undergoing first-ever catheter-based ablation at Charité-Campus Benjamin Franklin
  • age 18 years or older

Exclusion Criteria2

  • pregnancy
  • patient unable to provide written informed consent

Interventions

PROCEDUREQMODE intervention

Patients undergoing different forms of pulmonary vein isolation are being monitored for microembolic signals (MES) by transcranial ultrasound. For standard ablation, a Thermocool Smarttouch SF (Biosense Webster) catheter will be used (50 W, target ablation index of 550).

PROCEDUREQMODE+ intervention

Patients undergoing different forms of pulmonary vein isolation are being monitored for microembolic signals (MES) by transcranial ultrasound. For comparison, catheter ablation performed using very high power with a maximum of up tp 90 W (QMODE +) will be used.


Locations(1)

Charité-University Medicine Berlin, Campus Benjamin Franklin

Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05048004


Related Trials